2005 Press Releases

December 17
Sangamo BioSciences Announces Breakthrough Results at ICAAC Demonstrating Protection of Cells From HIV Infection Following Treatment with Zinc Finger Nucleases

November 30
Sangamo BioSciences Completes Enrollment and Treatment in Phase 1 Clinical Trial of ZFP Therapeutic in Diabetic Neuropathy

November 17
Sangamo BioSciences Reports on Registered Direct Offering

November 16
Sangamo BioSciences Announces Presentation at American Heart Association Meeting

November 11
Sangamo Announces Sale of $20.5 Million of Common Stock to Institutional and Strategic Investors and One Director

November 7
Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data at International Conference on Neuropathic Pain

November 2
Sangamo BioSciences Appoints Dr. Philip Gregory to Vice President, Research

October 31
Sangamo BioSciences to Present at the Rodman &Renshaw Techvest 7th Annual Healthcare Conference

October 27
Sangamo BioSciences Announces Third Quarter 2005 Conference Call and Webcast

October 27
Sangamo BioSciences Reports 2005 Third Quarter Financial Results and Recent Highlights (460k PDF)

October 20
Sangamo BioSciences Announces Third Quarter 2005 Conference Call and Webcast

October 13
Sangamo BioSciences to Present at the 2005 BIO InvestorForum

October 5
Dow AgroSciences, Sangamo BioSciences Announce Research and Commercial License Agreement in Plant Agriculture

September 29
Cystic Fibrosis Foundation Funds Production of Cell Lines by Sangamo BioSciences

September 28
Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing

September 26
UBS Global Life Sciences Conference to Webcast Sangamo Presentation

September 14
Sangamo BioSciences Announces Second Expansion of Research Collaboration With LifeScan Focused on Novel Diabetes Treatments

September 12
Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data at the Ocular Cell and Molecular Biology Conference

September 7
Novo Nordisk and Sangamo BioSciences Announce Agreement

July 26
Sangamo BioSciences to Present at America's Growth Capital 2nd Annual Growth Conference

July 19
Sangamo BioSciences Reports 2005 Second Quarter Financial Results (460k PDF)

July 12
Sangamo BioSciences Announces Second Quarter 2005 Conference Call and Webcast

June 27
Sangamo BioSciences Highlights Data From the 3rd Annual Meeting of the International Society for Stem Cell Research

June 21
Sangamo BioSciences ZFP Therapeutic(TM) Data to Be Presented at the 3rd Annual Meeting of the International Society for Stem Cell Research

June 16
Sangamo BioSciences to Present at the 25th William Blair and Company Annual Growth Stock Conference

June 13
Sangamo BioSciences Announces presentation of Data at American Diabetes Association Meeting

June 8
Sangamo BioSciences Announces Presentation of Data From Protein Production Program at 19th Meeting of the European Society for Animal Cell Technology

June 7
Sangamo BioSciences Highlights Data From the 8th Annual Meeting of the American Society of Gene Therapy

June 2
Sangamo BioSciences' Gene Correction Technology, Published in Nature Magazine, Is Seen as 'Considerable Step Towards a Successful Genetic-Engineering Approach to Treating Human Disease'

June 1
Sangamo BioSciences to Present Data From Its ZFP Therapeutic(TM) Programs at the 8th Annual Meeting of the American Society of Gene Therapy

May 26
Sangamo BioSciences Appoints Steven Mento, Ph.D. to Its Board of Directors

May 19
Sangamo BioSciences to Present at the Needham &Company Fourth Annual Biotechnology Conference

May 5
Sangamo BioSciences Initiates Clinical Trial for Novel Therapy for Diabetic Neuropathy

April 29
Sangamo BioSciences to Present at Rodman &Renshaw Techvest 2nd Annual Global Healthcare Conference

April 28
Sangamo BioSciences Reports 2005 First Quarter Financial Results (460k PDF)

April 21
Sangamo BioSciences Announces First Quarter 2005 Conference Call and Webcast

April 7
Sangamo BioSciences Announces Presentation of ZFN(TM) Gene Correction Data at American Society for Gene Therapy Stakeholders' Meeting

April 4
Sangamo BioSciences Announces Publication in Nature Demonstrating the Use of Its Zinc Finger Technology to Correct Human Genes

March 9
Sangamo BioSciences Appoints Margaret Liu, M.D. to Its Board of Directors

March 1
Sangamo BioSciences Announces presentation of Data from HIV Program at 12th Conference on Retroviruses and Opportunistic Infections

February 23
Sangamo BioSciences to Present at JMP Securities 4th Annual Research Conference

February 23
Sangamo BioSciences Announces Presentation by Clinical Collaborator of Data at Major HIV Medical Conference

February 22
Sangamo BioSciences to Present at Leerink Swann Inaugural Health Care Conference

February 17
Sangamo BioSciences to Present at BIO CEO and Investor Conference 2005

February 16
Sangamo BioSciences Reports 2004 Fourth Quarter and Year-End Financial Results (460k PDF)

February 9
Sangamo BioSciences Announces Fourth Quarter and Year-End 2004 Teleconference

January 20
Sangamo BioSciences to Present at 17th Annual Piper Jaffray Healthcare Conference

January 10
Sangamo BioSciences Files Investigational New Drug Application for ZFP Therapeutic to Treat Diabetic Neuropathy

January 6
Sangamo BioSciences to Present at 23rd Annual JP Morgan Healthcare Conference